Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Trinity Biotech PLC (NASDAQ: TRIB).

Full DD Report for TRIB

You must become a subscriber to view this report.


Recent News from (NASDAQ: TRIB)

Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q2 2018 Results - Earnings Call Transcript
Trinity Biotech plc (TRIB) Q2 2018 Earnings Conference Call July 19, 2018 11:00 AM ET Executives Joe Diaz – Lytham Partners Ronan O’Caoimh – Chief Executive Officer Kevin Tansley – Chief Financial Officer Analysts Jim Sidoti – Sidoti &...
Source: SeekingAlpha
Date: July, 19 2018 17:11
Trinity Biotech beats by $0.01, misses on revenue
Trinity Biotech (NASDAQ: TRIB ): Q2 EPS of $0.07 beats by $0.01 . More news on: Trinity Biotech PLC, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 19 2018 08:34
Trinity Biotech Announces Results for Q2, 2018
DUBLIN, Ireland, July 19, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2018. Quarter 2 Results ...
Source: GlobeNewswire
Date: July, 19 2018 08:25
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2018 Financial Results
DUBLIN, Ireland, July 12, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2018 on Thursday, July 19...
Source: GlobeNewswire
Date: July, 12 2018 10:17

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-143.973.974.003.96217,693
2017-03-105.685.735.735.68502
2017-03-095.675.665.755.54720,982
2017-03-085.755.645.855.5971,366
2017-03-075.975.796.015.7572,607

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-108601,50057.3333Short
2018-12-072,8009,89828.2885Cover
2018-12-0610058,8260.1700Cover
2018-12-0430,305115,81026.1679Cover
2018-12-0316,39441,24239.7507Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TRIB.


About Trinity Biotech PLC (NASDAQ: TRIB)

Logo for Trinity Biotech PLC (NASDAQ: TRIB)

Not available

 

Contact Information

 

 

Current Management

  • Ronan O Caoimh / CEO
  • Rory Nealon / CFO

Current Share Structure

  • Market Cap: $27,646,693 - 05/18/2018
  • Issue and Outstanding: 24,040,603 - 12/31/2016

 


Recent Filings from (NASDAQ: TRIB)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: July, 23 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 14 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: June, 07 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 03 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: April, 20 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 09 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 07 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 15 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: TRIB)

Daily Technical Chart for (NASDAQ: TRIB)


Stay tuned for daily updates and more on (NASDAQ: TRIB)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: TRIB)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TRIB is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TRIB and does not buy, sell, or trade any shares of TRIB. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/